Alvotech (NASDAQ:ALVOW) Sees Large Growth in Short Interest
by Amy Steele · The Cerbat GemAlvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totaling 9,314 shares, a growth of 899.4% from the March 15th total of 932 shares. Based on an average daily volume of 1,829 shares, the short-interest ratio is currently 5.1 days.
Alvotech Trading Up 4.0%
Alvotech stock traded up $0.01 during midday trading on Friday, reaching $0.26. 26 shares of the stock traded hands, compared to its average volume of 3,818. The firm has a fifty day moving average price of $0.33 and a two-hundred day moving average price of $0.74. Alvotech has a fifty-two week low of $0.15 and a fifty-two week high of $3.00.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.